Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Seasonal Influenza”

285 trials

Showing 20 of 285 results

Testing effectiveness (Phase 2)Study completedNCT01974895
What this trial is testing

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age

Who this might be right for
Influenza
GlaxoSmithKline 316
Large-scale testing (Phase 3)Study completedNCT01959945
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Flublok Quadrivalent (Recombinant Influenza Vaccine,Seasonal Formulation)

Who this might be right for
Influenza
Protein Sciences Corporation 219
Not applicableStudy completedNCT01282177
What this trial is testing

Influenza Vaccine Safety and Effectiveness in Healthcare Providers

Who this might be right for
Influenza
Dalhousie University 1,143
Large-scale testing (Phase 3)Study completedNCT01147081
What this trial is testing

Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2010/2011

Who this might be right for
Seasonal Influenza
Novartis Vaccines 142
Testing effectiveness (Phase 2)Study completedNCT06431607
What this trial is testing

Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults

Who this might be right for
Influenza, Human
GlaxoSmithKline 845
Post-approval studies (Phase 4)Active Not RecruitingNCT02957890
What this trial is testing

Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong

Who this might be right for
Influenza, Human
The University of Hong Kong 400
Early research (Phase 1)Study completedNCT05968989
What this trial is testing

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)WithdrawnNCT01037634
What this trial is testing

Safety and Efficacy of Oseltamivir in Children Younger Than One Year of Age

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT01072799
What this trial is testing

Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine

Who this might be right for
Seasonal Influenza
Novavax 4,560
Testing effectiveness (Phase 2)Study completedNCT02623322
What this trial is testing

MHAA4549A as Monotherapy for Acute Uncomplicated Seasonal Influenza A in Otherwise Healthy Adults

Who this might be right for
Influenza A
Genentech, Inc. 124
Post-approval studies (Phase 4)Study completedNCT03701061
What this trial is testing

Durability and Impact of the Seasonal Influenza Vaccine on H5 Induced B Cell Response

Who this might be right for
Influenza A Subtype H5N1 Infection
Emory University 12
Testing effectiveness (Phase 2)Study completedNCT00424086
What this trial is testing

Safety and Immunogenicity Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived)

Who this might be right for
Influenza
Alachua Government Services, Inc. 1,000
Post-approval studies (Phase 4)Study completedNCT00560066
What this trial is testing

Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions

Who this might be right for
Seasonal InfluenzaVaccine
Novartis Vaccines 1,398
Large-scale testing (Phase 3)Study completedNCT03859141
What this trial is testing

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 2,340
Not applicableStudy completedNCT02885246
What this trial is testing

Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015

Who this might be right for
Influenza, Human
GlaxoSmithKline 1,839
Large-scale testing (Phase 3)Study completedNCT01961947
What this trial is testing

Study of ASP7374, Cell-culture-derived Influenza Vaccine

Who this might be right for
InfluenzaVaccine
UMN Pharma Inc. 900
Large-scale testing (Phase 3)Study completedNCT05827978
What this trial is testing

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

Who this might be right for
Seasonal Influenza
ModernaTX, Inc. 8,411
Large-scale testing (Phase 3)Study completedNCT05431725
What this trial is testing

Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 2,202
Large-scale testing (Phase 3)Study completedNCT05415462
What this trial is testing

MRNA-1010 Seasonal Influenza Vaccine in Adults

Who this might be right for
Seasonal Influenza
ModernaTX, Inc. 6,102
Early research (Phase 1)WithdrawnNCT00966342
What this trial is testing

Rapid Evaluation of Seasonal Influenza Vaccine

Who this might be right for
Influenza
University of British Columbia 300
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation